Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

DrugCard is an AI-powered pharmacovigilance platform designed to help pharmaceutical companies, CROs, and drug safety teams automate routine PV processes and manage safety information more efficiently. The platform brings together global and local literature monitoring, regulatory intelligence, and adverse event management in one connected workflow. DrugCard supports PV teams in identifying relevant safety information faster, reducing manual screening workload, and maintaining transparent, audit-ready processes. Its literature monitoring module covers 121+ countries, 2,200+ local medical sources, and 100+ languages, including both global databases such as PubMed and local, non-indexed medical journals. The platform uses AI to support article pre-assessment, generate structured summaries, highlight relevant keywords, assist with translations, and help users prioritize publications that may require safety review. DrugCard also provides configurable workflows, automated notifications, reporting tools, QC functionality, audit trails, and case creation from literature. With additional modules for Regulatory Intelligence and Adverse Event Database management, DrugCard helps organizations track health authority updates, centralize safety data, support E2B workflows, and improve overall pharmacovigilance operations. Built for MAHs, QPPVs, LQPPVs, CROs, regulatory teams, and PV professionals, DrugCard combines automation with human expert oversight to support compliant, scalable, and reliable drug safety management.

Description

Enhance your biomedical research endeavors through the most extensive database of biomedical literature available globally. By utilizing a thorough and contemporary search process, you can access a wealth of biomedical evidence that is both comprehensive and pertinent. Streamline your systematic searches with automated query generation facilitated by user-friendly search forms. Discover critical insights into drug-disease interactions and drug-drug relationships, meticulously curated through extensive indexing efforts. The rapid evolution of biomedical research and development necessitates access to exhaustive information, allowing you to identify potential risks by evaluating all known data. Furthermore, you can monitor safety standards to ensure compliance with regulations while unveiling connections that foster innovation. Embase stands out as a distinctive medical literature database where depth of content exceeds mere quantity. With Emtree indexing of full-text resources and specialized search terminology, you are empowered to locate all significant and up-to-date information, including data that may elude other databases. Scroll down to understand the compelling reasons why regulatory bodies endorse Embase within their best practice recommendations, ensuring that your research is not only thorough but also aligned with industry standards. This commitment to excellence in biomedical literature further positions Embase as an indispensable tool for researchers and practitioners alike.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

CoVigilAI

Integrations

CoVigilAI

Pricing Details

individual
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

DrugCard

Founded

2021

Country

Estonia

Website

drug-card.io

Vendor Details

Company Name

Elsevier

Country

Netherlands‎

Website

www.embase.com/landing

Product Features

Alternatives

Ovid Reviews

Ovid

Wolters Kluwer
Compier Literature Screening Reviews

Compier Literature Screening

Techsol Life Sciences